VRX
Valeant Pharmaceuticals International Inc
Valeant Pharmaceuticals International Inc 13F Holders
VRX Stock Ownership Activity
- # of activities:
- 6
- AVG reported price*:
- $131.83
6 value investing gurus have made changes to the Valeant Pharmaceuticals International Inc (VRX) position according to the gurus' 2014 Q1 SEC quarterly report(s). VRX has been bought (as a new position) by 1 guru(s), the number of VRX shares has been increased by 2, decreased by 3 super investor(s).
Which gurus or hedge funds bought VRX in 2014 Q1?
According to the 2014 Q1 SEC filing(s) Valeant Pharmaceuticals International Inc (VRX) has been bought by 3 gurus / funds: Ole Andreas Halvorsen - Viking Global Investors (added shares +11.61%), Stephen Mandel - Lone Pine Capital (added shares +13.67%) and Daniel Loeb - Third Point (new buy).
To see more about who is investing in Valeant Pharmaceuticals International Inc (VRX), please go to the VRX ownership page.
* Shares, change to shares, sold shares, shares held after: split-adjusted.
* Current price: this can be a delayed price and may not reflect the real-time market value, however it is too close.
* Value or Price: If the security is completely sold out, we show the reported value (or price) prior to the actual period.
* AVG reported price: weighted average based on position sizes. Larger holdings have proportionally more influence on the average. This doesn't represent the actual buy or sell price. It is the split-adjusted average price of the securities as of the last day of the reported period.
* Held since / Held for: calculated since the latest "new buy" position. If the security was previously exited and re-entered, only the most recent holding period is counted.